Get started
Author

Ori Zelichov

Observed names: O. Zelichov, Zelichov, Ori
OpenAlex ID: A5045568372
Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer
2021 · Jonathan M. Loree, Yucai Wang, et al. · Clinical Cancer Research · 40
PDF
Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment
2016 · Lee Admoni-Elisha, Itay Nakdimon, et al. · PLoS ONE · 20
PDF
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
2019 · Stephen R. Fairclough, Lesli A. Kiedrowski, et al. · Experimental Hematology and Oncology · 19
PDF
A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks
2020 · Lior Zimmerman, Ori Zelichov, et al. · Scientific Reports · 7
PDF
A novel deep learning pipeline for cell typing and phenotypic marker quantification in multiplex imaging
2022 · Ettai Markovits, Tal Dankovich, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors
2021 · Shumei Kato, Robert Porter, et al. · European Journal of Cancer · 5
Predicting response to pembrolizumab in non-small cell lung cancer, by analyzing the spatial arrangement of tumor infiltrating lymphocytes using deep learning.
2021 · Efrat Ofek, Jair Bar, et al. · Journal of Clinical Oncology · 4
Abstract 4316: Identification of tertiary lymphoid structures from H&E slides using deep learning analysis of nuclear morphology is associated with favorable survival in colorectal cancer patients
2023 · Becky Arbiv, Tal Dankovich, et al. · Cancer Research · 2
1289 Predicting response to immune checkpoint inhibitors (ICI) in non-small-cell lung cancer (NSCLC) by combining spatial analysis of cells and RNA sequencing data from biopsies using deep learning (DL)
2022 · Ettai Markovits, David Soong, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict response to HER2-targeted therapy.
2018 · Dazhi Liu, Michael David Offin, et al. · Journal of Clinical Oncology · 1
Supplementary Methods from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Figure S1 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Table S3 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Table S2 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Figure S3 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Figure S2 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Table S1 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Table S3 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Methods from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Table S2 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Figure S3 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Figure S1 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplementary Figure S2 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Supplemental Table S1 from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
2023 · Jonathan M. Loree, Yucai Wang, et al.
Works count: 36
Citation count: 104
H-index: 5
I10-index: 3
Year
Topic
Type